Velussi M, Cernigoi AM, Viezolli L, Dapas F, Caffau C, Zilli M (1993). Silymarin reduces hyperinsulinemia, malondialdehyde levels, and daily insulin need in cirrhotic diabetic patients. Current Diabetic Res, 53: 533-545.
Kamenova P (2006). Improvement of insulin sensitivity in patients with type 2 diabetes mellitus after oral administration of alpha-lipoic acid. Hormones (Athens) 5, 251–258.
Ziegler D, et al. (2006). Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial. Diabetes Care 29, 2365–237010. 2337/dc06-1216.
Dosage & Directions for Use:
Adults: Take one capsule 3 times daily. Use for a minimum of 3 weeks to see beneficial effects.
Consult a health care practitioner for use beyond 30 days.
Do not use if you are pregnant or breastfeeding. Consult a health care practitioner if symptoms persist or worsen, prior to use if you have gallstones or a bile duct obstruction, stomach ulcers or excess stomach acid, or if you have diabetes. If you experience sweating, paleness, chills, headache, dizziness and/or confusion, discontinue use and consult a healthcare practitioner (as these may be symptoms of severe low blood sugar levels).
Dosage & Quantity:
In dry place in a tightly sealed package at the room temperature. Keep away from children.
Product shelf life: 2 years.
Product has been approved by:
Natural Product Number (NPN): 80079066
The information on this page is intended for medical and pharmaceutical workers. Visitors to the site should not use this information as medical advice and guidance. Choice and prescription drugs, as well as control over their application, can only be performed by a doctor who always takes the individual characteristics of the patient into account.